Xconomy | Boston - Business + Technology in the Exponential Economy

Biotech, pharma, acquisitions

Parexel To Purchase ClinPhone for $182M

Gregory T. Huang 6/13/08

Parexel International (NASDAQ: PRXL), based in Waltham, MA, announced today that it will acquire ClinPhone, a U.K.-based firm that provides voice response and electronic data capture for drug companies, for some $182 million. Parexel, which does clinical research and consulting for the biotech and pharmaceutical industry, has arranged a $300 million credit facility with JPMorgan Chase Bank N.A. and Keybank National Association to pay for the acquisition and to refinance both companies’ debt. The deal is expected to close by the end of September.

Gregory T. Huang is the Editor of Xconomy Seattle. You can e-mail him at gthuang@xconomy.com or call 206-624-2249.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.